The Global Exosome Research Market Size is valued at 209.04 million in 2022 and is predicted to reach 3020.33 million by the year 2031 at a 34.72% CAGR during the forecast period for 2023-2031.
The demand for exosome research products has grown due to the growing use of specialized testing services such as liquid chromatography-mass spectrometry, RNA sequencing, wet chemistry, gene expressions, and various other testing services. These testing services are also increasingly used because of their ability to produce precise and accurate results, which has increased their use by end users.
The rising incidence of cancer, improvements in exosome separation and analysis techniques, and increased exosome-based advanced applications are expected to fuel market expansion. The rising number of cancer patients directly impacts the increased demand for exosomes. Exosome use in treating cancer is anticipated to increase due to the increased number of cancer cases, which is anticipated to boost the market. Furthermore, due to their improved passive targeting, enhanced tiny size, native nature, and capacity to traverse biological barriers, exosomes produced from body regions are intriguing candidates for anti-cancer vaccines. As a result, there is a clear correlation between the rise in cancer cases in hospitals and the demand for exosomes for therapeutic and diagnostic purposes.
However, several technological issues must be resolved to integrate exosomes in various applications successfully. One of the main obstacles to expanding the exosome market is this.
Additionally, research and development involving exosomes decreased due to nationwide lockdown regulations, supply chain disruptions, and investment shifts toward COVID-19-related products. Despite the negative effects, the COVID-19 pandemic has created several new opportunities for using exosomes in developing COVID-19 vaccines and therapies. This, in turn, is anticipated to accelerate industrial growth.
- The US (FDA) approved a protocol amendment for an ongoing clinical trial of Aethlon Hemopurifier for patients with severe COVID-19 in July 2022, according to an announcement made by Aethlon Medical, Inc., a medical therapy company focused on developing products for the diagnosis and treatment of cancer and life-threatening infectious diseases.
- ExoDX introduced the ExoDx Prostate Test Home Collection Kit in April 2020 for individuals concerned about prostate health. For doctors and their patients who share the frustration, anxiety, and dread of the patient with advanced prostate cancer, the home collection kit offers an immediate and affordable alternative that permits a telemedicine/telehealth option.
Some of the Exosome Research market players are:
- Thermo Fisher Scientific
- System Bioscience
- Hitachi Chemical
- Malvern Panalytical
- Sistemic Scotland Limited
- NX PharmaGen
- Miltenyi Biotec
- AMS Biotechnology
- Norgen Biotek
- Novus Biologicals
- Pall Corporation
The exosome research market is segmented based on products & services, disease indications, applications and end users. Based on products & Services, the Exosome Research market is segmented as kits and reagents, instruments and services. By indication, the Exosome Research market is segmented into cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases. By application, the market is segmented into biomarkers, vaccine development, tissue regeneration and other applications. By end users, the market is segmented into academic & research institutes, pharmaceutical and biotechnology companies, hospitals & clinical testing laboratories.
Based On Product, The Kits & Reagents Segment Is A Major Contributor In The Exosome Research Market
The kits & reagents category will hold a major share of the global Exosome Research market in 2022. Since circulating exosome microRNAs hold great promise as biomarkers, exosomes must be thoroughly characterized. As a result, simple-to-use reagents and kit designs have been created, promoting the usage of these tools in exosome research. The crucial isolation and purification steps are also necessary for exosome research methods, hastening their widespread commercialization. From various biological fluids, such as serum, plasma, and blood, these kits can extract exosomes and EV. Specialty purification and spin-column technology are also used to purify exosomes; these methods outperform traditional isolation methods, such as density gradient centrifugation and ultracentrifugation. Exosomes and other extracellular vesicles can be produced in large quantities with this technology from an incredibly clean cell culture media.
The Neurodegenerative Disorders Segment Witnessed Growth At A Rapid Rate
The neurodegenerative disorders segment is projected to grow rapidly in the global Exosome Research market. The major cause of disability and mortality and a significant financial burden on healthcare systems continue to be neurodegenerative disorders. Exosomes have a role in removing waste products from the nervous system, maintaining myelin sheath, and maintaining intercellular communication. Increased frequency of neurodegenerative disorders, improvements in exosome isolation and analysis methods, and an increase in the number of complex exosome applications are anticipated to be the causes of this rise.
The North America Exosome Research Market Holds A Significant Regional Revenue Share
The North America Exosome Research market is expected to register the highest market share due to improved healthcare structures, strong public regulations, many multinational corporations, and significant public awareness of diagnostics and healthcare. The use of exosome-based medications in treating cancers such as cancer of the skin, breast, lung, and pancreatic has been the subject of numerous government-funded studies of research. Clinical trials are being carried out in the United States thanks to sponsorship from businesses like Merck and Exosome Diagnostic and partnerships with schools like Yale and Michigan State.
Furthermore, government funding for these projects is superior, and most of the studies were done for neoplasms. In addition, Asia Pacific is projected to increase in the global Exosome Research market. The rise in government financing for discovering new biomarkers and the growing incidence of chronic diseases like cancer and cardiovascular disease is boosting the regional demand. The category is also expected to rise due to expanding research and development efforts to create novel medications, diagnostic techniques, and treatment choices.
Exosome Research Market Report Scope:
Market size value in 2022
USD 209.04 Mn
Revenue forecast in 2031
USD 3020.33 Mn
Growth rate CAGR
CAGR of 34.72 % from 2023 to 2031
Representation of revenue in US$ Billion and CAGR from 2023 to 2031
2019 to 2022
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
Products & Services, Indications, Applications And End Users
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia
Thermo Fisher Scientific, System Biosciences, Bio-Techne, Lonza, QIAGEN, ExoDx, Hitachi Chemical, Aethlon Medical, NanoSomiX, Malvern Panalytical, Sistemic Scotland Limited, NX PharmaGen, Miltenyi Biotec, AMS Biotechnology, Norgen Biotec, Novus Biologicals, BioVision, Pall Corporation, Exopharm, and EverZom.
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and available payment methods
Explore pricing alternatives that are customized to your particular study requirements.